Neuronetics, Inc.

STIMReported to SECin USCIK 0001227636Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

4
Form 4 lines at Neuronetics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Chernett Jorey—Open-market sell$321100 sharesAug 17, 2026Chernett Jorey$321Sell · Aug 17Open-market sell100Aug 17, 2026
Chernett Jorey—Open-market buy$44,24014,000 sharesAug 17, 2026Chernett Jorey$44,240Buy · Aug 17Open-market buy14,000Aug 17, 2026
Naor NirEVP, CFO & TreasurerAwardnothing paid500,000 sharesJul 23, 2026Naor NirEVP, CFO & Treasurernothing paidAward · Jul 23Award500,000Jul 23, 2026
Chernett Jorey—Open-market buy$62,30035,000 sharesJul 15, 2026Chernett Jorey$62,300Buy · Jul 15Open-market buy35,000Jul 15, 2026